News & Events

News

March 13, 2019

Precision BioLogic Inc., a leading developer of hemostasis diagnostic products, is pleased to announce FDA 510(k) clearance and the launch of its CRYOcheck™ Factor VIII Inhibitor Kit in the U.S. This clearance follows approvals received from regulatory authorities in Canada, the European Union, Australia, and New Zealand, where the kit launched in February of this year.

February 11, 2019

Precision BioLogic Inc., a leading developer of hemostasis diagnostic products, is pleased to announce the availability of its new CRYOcheck™ Factor VIII Inhibitor Kit in Canada, the European Union, Australia, and New Zealand following market authorization by Health Canada and respective in-country regulatory authorities last month.

Events

Here’s a list of conferences we’ll be attending this year. If you’re planning on attending any of the same shows, be sure to swing by our booth for a chat because, after all, it’s you we want to see.

May
09 to 11
Vancouver, BC - Visit Precision BioLogic & Affinity Biologicals at Booth 503
Jul
06 to 10
Melbourne, Australia - Visit Precision BioLogic & Affinity Biologicals at Booth 735